retatrutide mechanism gip glp-1 glucagon triple agonist Reta clinical trial data & dosing — a must read (Reta) isn't just another GLP-1. It's a triple-agonist peptide studied in Phase 3 trials for metabolic health — targeting GLP-1, Retatrutide and Insulin Resistance in

Redox Biol 60:102605

~ AlphaMD Testosterone replacement therapy (TRT) has become an increasingly popular treatment option for both men and women experiencing symptoms related to low testosterone levels

Effect of mannose targeting of hydroxyl PAMAM dendrimers on cellular and organ biodistribution in a neonatal brain injury model

We prescribe CJC-1295 with Ipamorelin and Tesamorelin because the injectable evidence is strong and the results in our South Florida patient population are consistent and measurable

Peptides are short chains of amino acids that act as signals, instructing your body to carry out specific functions, such as growth hormone release

Use of NP Thyroid in patients with diabetes mellitus or adrenal cortical insufficiency may worsen the intensity of their symptoms